SCHEMBL8220196

SCHEMBL8220196

Cc1cc(CI)ccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
DAO P14920 1/20 0.44
MMP13 P45452 1/20 0.41
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
MPO P05164 1/20 0.38
ACHE P22303 1/20 0.37
SOS1 Q07889 1/20 0.37
PTPN7 P35236 1/20 0.36
DUSP3 P51452 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2093201 0.82 DAO (0.47) SLC6A2SLC6A4SLC6A3DAOMMP13
SCHEMBL27057408 0.82 DAO (0.44) SLC6A2SLC6A4SLC6A3DAOHDAC1
SCHEMBL17971122 0.81 ESR1 (0.54) SLC6A2SLC6A4SLC6A3DAOMMP13
SCHEMBL12993418 0.79 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3DAOMMP13
SCHEMBL6953517 0.79 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3DAOMMP13
SCHEMBL6416441 0.78 LMNA (0.41) PTGS1PTGS2ESR1ESR2
SCHEMBL8065437 0.78 HTT (0.45) DAOMPO
SCHEMBL2093205 0.77 CYP4F2 (0.50) SLC6A2SLC6A4SLC6A3DAOMMP13
SCHEMBL177531 0.77 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3DAOMMP13
SCHEMBL20560328 0.77 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3DAOMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2475659-B1 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE HOFFMANN LA ROCHE (CH) 2015-10-28 EP disclosed
WO-2008002671-A2 METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2008-01-03 WO disclosed
WO-2007139856-A2 HETEROBICYCLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS, INC. (US) 2007-12-06 WO disclosed
WO-2007088181-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-08-09 WO disclosed